Updated Immunization Schedule Presented for Adults for 2024
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 11, 2024 -- In a clinical guideline published online Jan. 11 in the Annals of Internal Medicine, an updated immunization schedule is presented for U.S. adults for 2024.
On behalf of the Advisory Committee on Immunization Practices (ACIP), Neil Murthy, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues break down the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2024.
The authors note that changes to the 2024 adult immunization schedule include new COVID-19 vaccine recommendations, including that all adults should receive at least one dose of the updated vaccine. Respiratory syncytial virus vaccination is a new addition to the adult immunization schedule, with routine use of Abrysvo (Pfizer) recommended during pregnancy (at 32 to 36 weeks of gestation); for older adults (aged 60 years and older), shared clinical decision-making is recommended for vaccination with either Abrysvo (Pfizer) or Arexvy (GlaxoSmithKline).
"The CDC's Advisory Committee on Immunization Practices' Recommended Adult Immunization Schedule, United States, 2024 confirms ACIP's competence in preparing current, evidence-based vaccination recommendations," Scott C. Ratzan, M.D., from City University of New York's Graduate School of Public Health and Health Policy in New York City, and colleagues write in an accompanying editorial. "However, it also demonstrates that CDC has not moved sufficiently beyond merely providing information to clinicians and the public to persuasive communication."
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
THURSDAY, April 25, 2024 -- More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV)...
2011 to 2021 Saw Increase in Vaccination Timeliness for Infants
MONDAY, April 15, 2024 -- From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.